openPR Logo
Press release

80% of people with diabetes live in low and middle income countries

12-17-2012 08:02 PM CET | Health & Medicine

Press release from: Fleming Gulf

80% of people with diabetes live in low and middle income

Diabetes is a growing epidemic currently affecting around 7% of the world’s population; thus threatening health and economic prosperity. According to World Health Organisation (WHO) more than 346 million people worldwide have diabetes. This number is likely to be more than double by 2030 without intervention. Almost 80% of diabetes deaths occur in low- and middle-income countries, while the Middle East ranks as one of the leading countries with diabetes prevalence.

According to the news publishesd in Hindustan Times Diabetes affects 50.8 million adults in India. There are no absolute numbers for children affected.“95% of those diagnosed (with type-2 diabetes) are overweight or obese, the 5% with normal weight have abdominal fat and high body fat percentage” says Dr Anoop Misra, chairman, Fortis C-DOC network centre for diabetes, obesity and cholesterol. Diabetes affects millions of people and is a very serious lifelong health problem. However, keeping diabeates in control is a difficult task as more than half of the care for diabetes is self driven.

Nearly 60% of Indians suffering from diabetes remain undiagnosed, said the International Diabetes Federation chief Jean Claude Mbanya at a diabesity summit held in Mumbai on Thursday.
The International Diabetes Federation (IDF) anticipates that by 2030, 11% of the Middle East and North Africa region or 59.7 million people will be living with diabetes. Six out of the world’s top ten countries with the highest prevalence of diabetes are in the region. IDF estimates that there are as many as 19.2 million people still undiagnosed. The new regional figures also show that the prevalence of type 2 diabetes in the region for younger age groups is substantially higher than the global average.

As a result of these compelling statistics, Fleming Gulf is organizing “3rd Annual International Diabetes Summit” which will help to bring the latest information on prevention and diabetes care. This conference will explore the new and upcoming ways being explored globally to prevent and control the diabetes epidemic which has affected millions of life throughout the world.

Fleming Gulf delivers the most comprehensive business events by leveraging our network of industry influencers with specialist knowledge to provide organisations the winning edge that makes a difference in their decision making in today's competitive business landscape.

Fleming Gulf
286/287 Amar Jyothi Layout
West Wing, Domlur
Bangalore – 560071
Karnataka, INDIA

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 80% of people with diabetes live in low and middle income countries here

News-ID: 245010 • Views:

More Releases for Diabetes

Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size? The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools. The diabetes pen market is projected to grow strongly, reaching $40.17 billion
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28). According to Type-2 Diabetes Market
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their